Form Approved
OMB Control No.: 0920-1154
Expiration date: 03/31/2026
Baseline Survey |
INTRODUCTION Thank you for taking the time to complete this baseline survey! This baseline survey supports ongoing evaluation of CDC’s One Health Zoonotic Disease Prioritization (OHZDP) Process to measure the impact of the OHZDP around the world. The purpose of this baseline survey is to collect information before the OHZDP workshop to later learn how locations have advanced One Health efforts after engaging in the OHZDP Process.
This survey will be issued at three additional time points (6 months, 1.5 years, and 3 years after your OHZDP workshop). After completing each survey, you will be able to track your location’s progress to advance One Health and address the priority zoonotic diseases after the OHZDP workshop.
Information provided may be used by CDC for monitoring and evaluation. Responses may be aggregated with other locations in a summary report on OHZDP impacts globally. |
NOTES:
|
1 Very poor 2 Poor 3 Fair 4 Good 5 Very good |
☐ Established a formal multisectoral, One Health coordination mechanism with decision making authority and acts to strengthen or develop collaboration, communication, and coordination across the sectors responsible for addressing zoonotic diseases ☐ Established informal multisectoral, One Health coordination mechanism for addressing zoonotic diseases ☐ Used the Tripartite Zoonoses Guide Multisectoral, One Health Coordination Mechanism Operational Tool (MCM OT) ☐ Established political support for One Health and/or zoonotic diseases ☐ Established legislation for One Health coordination ☐ [Developed or updated] National One Health Joint Plan of Action ☐ Developed One Health strategic plan or national framework ☐ Developed One Health action plans (One Health operational plans, implementation plans) ☐Developed Memorandums of Understanding (MoU) or Memorandums of Agreement (MoA) across One Health sectors ☐ Established technical working groups for any zoonotic diseases ☐ Met regularly across One Health sectors to address zoonotic diseases ☐ Established funding for any zoonotic diseases ☐ Conducted a OHZDP workshop previously (ex. national level, subnational level, etc) ☐ Conducted a One Health capacity assessment and/or needs assessment
|
☐ Conducted surveillance assessments/evaluations for zoonotic diseases ☐ Developed a strategy or plan for coordinated surveillance for zoonotic diseases across One Health sectors ☐ Used the Tripartite Zoonoses Guide Surveillance and Information Sharing Operational Tool (SISOT) ☐ Used other One Health tool(s) to enhance surveillance for zoonotic disease across sectors ☐if selected: Specify tool(s):___________ ☐ Established a surveillance system for zoonotic diseases ☐ Developed systems for sharing surveillance data and information for zoonotic diseases across One Health sectors ☐ Collected epidemiologic data for zoonotic diseases ☐ Developed or coordinated case definitions across One Health sectors for any zoonotic diseases |
4. To date, please indicate below which of the following outcomes have been accomplished for LABORATORY in (country): ☐ Conducted laboratory assessments/evaluations for zoonotic diseases ☐ Developed a strategy or plan for strengthening laboratory capacity for zoonotic diseases across One Health sectors ☐ Established a mechanism for routine laboratory data and information sharing for zoonotic diseases across One Health sectors ☐ Shared laboratory protocols for zoonotic diseases between animal health and human health laboratories ☐ Procured laboratory equipment and supplies for zoonotic diseases ☐ Established diagnostic capacity (e.g. acquired diagnostics, decreased testing time, genomic sequencing, etc.) for zoonotic diseases ☐Collected samples to test for zoonotic diseases ☐ Used a One Health tool(s) to enhance laboratory capacity for zoonotic disease ☐if selected: Specify tool(s):_____________
|
5. To date, please indicate below which of the following outcomes have been accomplished for PREPAREDNESS AND PLANNING in (country): ☐ Developed joint preparedness plans for zoonotic diseases across One Health sectors ☐ Developed joint Standard Operating Procedures (SOPs) for zoonotic diseases across One Health sectors ☐ Conducted a simulation exercise(s) for zoonotic diseases ☐ Conducted a joint risk assessment for zoonotic diseases ☐ Used the Tripartite Zoonoses Guide Joint Risk Assessment Operational Tool (JRA OT) for zoonotic diseases ☐ Conducted WHO’s Preparedness and Response (RePrep) workshop ☐Conducted research activities for any zoonotic disease ☐ Used other One Health tool(s) to support preparedness and planning for zoonotic disease ☐if selected: Specify tool(s):_____________ |
6. To date, please indicate below which of the following outcomes have been accomplished for OUTBREAK RESPONSE in (country): ☐ Established a protocol to conduct coordinated or joint investigations and responses for zoonotic diseases across One Health sectors ☐ Established trained One Health Rapid Response Team(s) ☐ Conducted joint investigation or response with One Health sectors for zoonotic diseases ☐Involved other One Health sectors to participate in an existing rapid response team ☐ Conducted a review (e.g. Early Action Review, After Action Review) for zoonotic diseases during or after an investigation or response across One Health sectors ☐ Used a One Health tool(s) to support outbreak response for zoonotic disease: ☐if selected: Specify tool(s):_____________ |
7. To date, please indicate below which of the following outcomes have been accomplished for PREVENTION AND CONTROL in (country): ☐ Implemented prevention and control measures (e.g. vaccination or education campaigns, quarantine, culling, etc.) for zoonotic diseases in coordination with the other One Health sectors ☐ Developed a joint plan or policy document outlining prevention and control strategies for zoonotic diseases (e.g. national plans) ☐ Procured resources (e.g. vaccines, treatment, etc.) for zoonotic diseases ☐ Developed early prevention measures to prevent zoonotic disease spillover from animals to people ☐ Developed early prevention measures to prevent zoonotic disease spillback from people to animals ☐ Used a One Health tool(s) to support prevention and control for zoonotic diseases ☐if selected: Specify tool(s):_____________
|
8. To date, please indicate below which of the following outcomes have been accomplished for WORKFORCE CAPACITY in (country): ☐ Incorporated zoonotic diseases into a strategy or plan for educating, training, or strengthening a One Health workforce ☐ Conducted a review of current One Health workforce trainings ☐ Developed One Health curriculum for workforce training programs ☐ Conducted sector-specific trainings on zoonotic diseases ☐ Conducted joint trainings across One Health sectors on zoonotic diseases ☐ Used a One Health tool(s) to support One Health workforce capacity ☐if selected: Specify tool(s):_____________
|
9. To date, please indicate below which of the following outcomes have been accomplished for RISK COMMUNICATION AND COMMUNITY EDUCATION in (country): ☐ Developed a One Health strategy and plan for risk reduction, risk communication and/or community engagement for zoonotic diseases ☐ Established a platform to develop joint communications across One Health sectors ☐ Developed a network, messaging group, or listserv of One Health partners for One Health information sharing ☐ Developed educational materials on zoonotic diseases for use during an outbreak/event ☐ Established outreach or education to the community on zoonotic diseases (e.g. social media, newsletters, brochures, etc.) ☐ Used a One Health tool for risk communication and community education for zoonotic disease
|
10. Has your country participated in any of the following: ☐ Joint External Evaluation ☐ International Health Regulations (IHR) State Party Self-Assessment Annual Report (SPAR) ☐ Pathway to Veterinary Services (PVS) ☐ IHR-PVS National Bridging Workshop ☐ National Action Plans for Health Security (NAPHS) ☐ Global Laboratory Leadership Program ☐ OHZDP workshop If selected, identify for which level an OHZDP has been conducted: ☐ Regional level (>1 country) ☐ National level ☐ Subnational level ☐ Prioritization of zoonotic diseases using a methodology other than the OHZDP process
|
11. Has any zoonotic disease been incorporated into any of the following [mark all that apply]: ☐ Laws or regulations ☐ Funding proposals (e.g. Pandemic Fund) ☐ Joint External Evaluation ☐ International Health Regulations (IHR) State Party Self-Assessment Annual Report (SPAR) ☐ Pathway to Veterinary Services (PVS) ☐ IHR-PVS National Bridging Workshop ☐ National Action Plans for Health Security (NAPHS) ☐ National One Health Joint Plan of Action ☐ Other -----text optional |
12. Has [LOCATION NAME] conducted any other types of prioritizations using the OHZDP methodology (e.g. sector-specific, non-zoonotic disease, etc.)? ☐ Yes ☐if selected: Specify type of prioritization: ______________ ☐ No ☐ Unsure |
13. What are you hoping that conducting an OHZDP would accomplish for your location? |
|
14. Is there anything else you would like to share with CDC’s One Health Office? (optional) |
|
Thank you for taking the time to complete this baseline survey. You will be able to track your progress after the workshop at various time intervals to monitor and evaluate the impacts of the OHZDP Process in your location.
If you have any further comments or questions, please feel free to contact CDC’s One Health Office at [email protected]. |
Public reporting burden of this collection of information is estimated to average 15 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB Control Number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC/ATSDR Reports Clearance Officer, 1600 Clifton Road NE, MS H21-8, Atlanta, Georgia 30333; ATTN: PRA 0920-1154
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
Author | Courey, Elizabeth (CDC/NCEZID/OD) |
File Modified | 0000-00-00 |
File Created | 2025-05-19 |